Le Loupp Anne-Gaelle, Bach-Ngohou Kalyane, Bettan Armel, Denis Marc, Masson Damien
Inserm UMR913, institut des maladies de l'appareil digestif, Université de Nantes, CHU Hôtel-Dieu, 1, place Alexis Ricordeau, 44093 Nantes, France - Laboratoire de Biochimie, institut de biologie, CHU Nantes, 9, quai Moncousu, 44093 Nantes, France.
Inserm UMR913, institut des maladies de l'appareil digestif, Université de Nantes, CHU Hôtel-Dieu, 1, place Alexis Ricordeau, 44093 Nantes, France.
Med Sci (Paris). 2015 Jun-Jul;31(6-7):617-21. doi: 10.1051/medsci/20153106014. Epub 2015 Jul 7.
Prostaglandin D2 (PGD2) and derivatives are lipid mediators involved in the control of the intestinal epithelial barrier homeostasis. Their involvement in the pathophysiology of chronic inflammatory bowel disease (IBD) is still debated. Several results highlight the duality of PGD2 as an anti- or pro-inflammatory mediator. This duality seems to be related to a differential expression of its receptors by intestinal epithelial cells and the surrounding immunocompetent cells. The enteric glial cells from the enteric nervous system (ENS) express the lipocalin-type-prostaglandin D synthase and secrete PGD2 and 15d-PGJ2. The protective role of the ENS in the homeostatic control of the epithelial intestinal barrier and its involvement in the pathogenesis of IBD have already been demonstrated. Thus, these lipid mediators seem to be new actors of the neuro-glio-epithelial unit and could play a crucial role maintaining gut barrier integrity.
前列腺素D2(PGD2)及其衍生物是参与肠道上皮屏障稳态控制的脂质介质。它们在慢性炎症性肠病(IBD)病理生理学中的作用仍存在争议。一些研究结果突出了PGD2作为抗炎或促炎介质的双重性。这种双重性似乎与肠道上皮细胞和周围免疫活性细胞对其受体的差异表达有关。来自肠神经系统(ENS)的肠神经胶质细胞表达脂质运载蛋白型前列腺素D合酶,并分泌PGD2和15d-PGJ2。ENS在肠道上皮屏障稳态控制中的保护作用及其在IBD发病机制中的作用已经得到证实。因此,这些脂质介质似乎是神经-神经胶质-上皮单元的新参与者,可能在维持肠道屏障完整性方面发挥关键作用。